Asmo Pasanen
About Asmo Pasanen
Asmo Pasanen is the Sr. Director of Value, Access, Pricing & HEOR, Major Markets at Bristol Myers Squibb in Boudry, Neuchâtel, Switzerland, with extensive experience in market access and pricing across various pharmaceutical companies.
Current Role at Bristol Myers Squibb
Asmo Pasanen currently serves as the Sr. Director, Value, Access, Pricing & HEOR for Major Markets at Bristol Myers Squibb in Boudry, Neuchâtel, Switzerland. In this role, he is responsible for leading strategies related to market access, pricing, and health economics outcomes research (HEOR) across major markets. His role focuses on ensuring that innovative therapies are accessible and affordable to patients globally.
Previous Experience at Bristol Myers Squibb and Celgene
Before his current role, Asmo Pasanen held several senior positions at Bristol Myers Squibb and Celgene. From 2019 to 2021, he worked as Sr. Director, WW Hematology Value, Access & Pricing at Bristol Myers Squibb. At Celgene, his roles included Sr. Director, Pricing and Market Access, Worldwide Markets from 2018 to 2019; Sr. Director, Global Pricing & Market Access from 2017 to 2018; and Director, I&I Access & Pricing, EMEA from 2014 to 2017. His responsibilities included overseeing pricing and market access strategies across multiple regions and therapeutic areas.
Career at Amgen and Merck
From 2009 to 2014, Asmo Pasanen served as the Regional Pricing Lead at Amgen International in Zug, Switzerland. Prior to that, he spent five years as the Head of Access at Merck in Espoo, Finland from 2004 to 2009. His work at these companies involved developing and executing pricing strategies to optimize market access for innovative therapies.
Early Career and Contributions
Asmo Pasanen began his career in the pharmaceutical industry with roles in sales and marketing at Merck from 1996 to 2000 in Espoo, Finland. He then joined Pfizer in Helsinki, Finland, where he worked in marketing from 2000 to 2002. Following this, he served as Country Manager at ALK-Abelló A/S in Helsinki from 2002 to 2004. These roles provided him with a solid foundation in the commercial aspects of the pharmaceutical industry.
Educational Background
Asmo Pasanen's academic achievements include an M.Sc. from the University of Helsinki and an LLM from the University of Lapland. His educational background in both science and law has equipped him with a diverse skill set that supports his work in market access, pricing, and corporate affairs.